文献速递显微修复重建创面修复

穿支皮瓣治疗慢性骨髓炎的疗效

The Efficacy of Perforator Flaps in the Treatment of Chronic Osteomyelitis.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

回顾性分析120例慢性骨髓炎患者,均行清创后穿支皮瓣重建,随访至少2年。皮瓣丢失率4.2%,复发率8.3%,一期缓解率91.6%,二期缓解率98.3%,截肢率1%。外周血管疾病和大血管受累是复发的显著预测因素,复发风险高5.1倍(p<0.05)。

要点

  • 穿支皮瓣联合彻底清创、骨重建和死腔填塞可获得91.6%的一期缓解率。
  • 外周血管疾病和大血管受累使慢性骨髓炎复发风险增加5.1倍。
  • 皮瓣丢失率4.2%,截肢率1%,并发症可接受。

核心结论

  • 穿支皮瓣在充分清创、骨重建和死腔填塞基础上治疗慢性骨髓炎可获得91.6%的一期缓解率和98.3%的二期缓解率。
  • 外周血管疾病和大血管受累是慢性骨髓炎复发的显著预测因素,复发风险高5.1倍(p<0.05)。

研究设计与样本

  • 纳入标准为慢性骨髓炎至少6周且术后随访至少2年。
  • 分析复发与合并症、清创频率、骨髓炎持续时间、肢体血管状态及死腔填塞方式的相关性。

主要发现

  • 皮瓣丢失率4.2%。
  • 复发率8.3%。
  • 一期缓解率91.6%,二期缓解率98.3%。
  • 截肢率1%。
  • 外周血管疾病和大血管受累的复发比值比为5.1倍(p<0.05)。

临床怎么用

  • 对慢性骨髓炎患者,在彻底清创、骨重建和死腔填塞后可使用穿支皮瓣覆盖创面。
  • 合并外周血管疾病或大血管受累者需警惕高复发风险,应加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of chronic osteomyelitis involves aggressive débridement followed by soft-tissue coverage. The dictum of muscle coverage being superior has been challenged by successful reports of coverage with skin flaps. The objective of this article is to evaluate the efficacy of perforator flaps for reconstruction of chronic osteomyelitis defects. METHODS: A retrospective review of 120 patients with chronic osteomyelitis who underwent débridement and reconstruction using perforator flaps from April of 2000 to November of 2015 was conducted. Inclusion criteria were cases with chronic osteomyelitis for a minimum of 6 weeks and with a follow-up of at least 2 years after surgery. Correlation between recurrence and the following factors was analyzed: comorbidities, frequency of débridement, duration of chronic osteomyelitis, limb vascular status, and method of dead space obliteration. The outcomes analyzed were flap loss, recurrence rate, primary remission rate, secondary remission rate, and amputation rate. RESULTS: The flap loss rate was 4.2 percent flap, the recurrence rate was 8.3 percent, the primary remission rate was 91.6 percent, the secondary remission rate was 98.3 percent, and the amputation rate was 1 percent. Significant predictors of recurrence were peripheral vascular disease and major vessel compromise, which had 5.1 times higher odds of recurrence (p < 0.05). CONCLUSIONS: Used with adequate débridement, bone reconstruction, and obliteration of dead space, a primary remission rate of 91.6 percent and a secondary remission rate of 98.3 percent were achieved using perforator flap. The predictors of chronic osteomyelitis recurrence were peripheral vascular disease and major vascular compromise. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hong JPJ, Goh TLH, Choi DH, et al. The Efficacy of Perforator Flaps in the Treatment of Chronic Osteomyelitis. Plast Reconstr Surg. 2017. PMID: 28654608. doi:10.1097/PRS.0000000000003460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。